We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Results 1 to 5 of 33
Most popular |Most recent

Chinese Ministry of Health issues guidance to strengthen anti-bribery control at public hospitals

China - September 6 2012 On August 1, 2012, the Ministry of Health of China (“MOH”) issued the draft Guidance on Strengthening Anti-Bribery Control at Public Hospitals....

Zhengyu Tang, Chen Yang, Scott Bass, James C. Stansel.

SFDA to enforce blacklist system for unsafe drug and device products

China - August 21 2012 Beginning October 1, 2012, China’s State Food and Drug Administration (SFDA), including its provincial counterparts, will implement a nationwide information disclosure system called the Drug Safety Blacklist (“Blacklist”), which includes medical device products as well....

Zhengyu Tang, Chen Yang, Scott Bass, James C. Stansel.

SFDA intends to further regulate packaging and labeling of medical devices imported to China

China - May 24 2012 On May 21, 2012, China’s State Food and Drug Administration (SFDA) issued a draft Notice on Further Regulating Labeling and Packaging of Medical Devices Manufactured Overseas....

Zhengyu Tang, Chen Yang.

Updates on international pricing issues for pharmaceutical and biologic products

USA, United Kingdom, China, European Union, France, Germany - May 18 2012 Sidley Austin LLP’s Global Life Sciences Team is pleased to provide you with this Global Pricing Newsletter, the first in a periodic series updating clients and friends of the firm on pricing issues around the world that may have an impact on pharmaceutical and biologic manufacturers’ legal and business strategies....

Trevor L. Wear, William A. Sarraille, Maarten Meulenbelt, Felix von Bredow, James C. Stansel.

NDRC takes serial measures to reduce drug prices

China - May 14 2012 It has long been a policy objective of the Chinese Government to reduce drug prices in China while ensuring drug quality....

Zhengyu Tang, Chen Yang.